Illustrative CasesIntraosseous Infusion Is Unreliable for Adenosine Delivery in the Treatment of Supraventricular TachycardiaGoodman, Ian Scott MD, CM*†; Lu, Christina Jennifer BS†Author Information From the *Baystate Medical Center, and †Tufts University School of Medicine, Springfield, MA. Disclosure: The authors declare no conflict of interest. Reprints: Ian Scott Goodman, MD, CM, Departments of Pediatric Emergency and Hospital Medicine, Baystate Children’s Hospital, 759 Chestnut St, Springfield, MA 01199 (e-mail: [email protected]). Pediatric Emergency Care: January 2012 - Volume 28 - Issue 1 - p 47-48 doi: 10.1097/PEC.0b013e31823f2429 Buy SDC Metrics Abstract Supraventricular tachycardia (SVT) is a common tachyarrhythmia in the pediatric population that can necessitate immediate treatment. Adenosine has been well studied as a mainstay treatment, but the methods of adenosine administration have not been very well delineated. The intraosseous technique has presented itself as a possible method of administration. We describe 2 cases in which adenosine was administered through bone marrow infusion to convert SVT without success. The cases we describe show that intraosseous is not a reliable method of administering adenosine to stop SVT. Both patients presented with SVT refractory to vagal maneuvers and difficult intravenous placement. Intraosseous access was achieved, but administration of adenosine at increasing doses was unable to successfully convert the arrhythmia. © 2012 Lippincott Williams & Wilkins, Inc.